Compounds > pirfenidone
Page last updated: 2024-08-23

pirfenidone and Reperfusion Injury

pirfenidone has been researched along with Reperfusion Injury in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's4 (50.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Atılgan, D; Deresoy, FA; Firat, F; Katar, M; Kölükçü, E1
Adamo, L; Bajpai, G; Barger, PM; Bhattacharya, D; Jiang, W; Kovacs, A; Mann, DL; Matkovich, SJ; Rocha-Resende, C; Schilling, JD; Staloch, LJ; Weinheimer, CJ1
Chen-Yoshikawa, TF; Date, H; Masuda, S; Okabe, R; Saito, M; Suetsugu, K; Takahagi, A1
Vinten-Johansen, J1
Krupnick, AS; Mannem, H1
Arumugam, TV; Brown, L; Margolin, SB; Shiels, IA; Taylor, SM1
Kaibori, M; Kamiyama, Y; Kwon, AH; Okumura, T; Uchida, Y; Yanagida, H; Yokoigawa, N1
Dosanjh, A1

Other Studies

8 other study(ies) available for pirfenidone and Reperfusion Injury

ArticleYear
The effects of pirfenidone on ischaemia-reperfusion injury in testicular torsion-induced rat model.
    Andrologia, 2021, Volume: 53, Issue:2

    Topics: Animals; Humans; Male; Malondialdehyde; Pyridones; Rats; Rats, Wistar; Reperfusion Injury; Spermatic Cord Torsion; Testis

2021
Modulation of subsets of cardiac B lymphocytes improves cardiac function after acute injury.
    JCI insight, 2018, 06-07, Volume: 3, Issue:11

    Topics: Animals; B-Lymphocyte Subsets; Diphtheria Toxin; Disease Models, Animal; Female; Heart Ventricles; Humans; Lipopolysaccharides; Lymphocyte Activation; Lymphocyte Depletion; Mice; Myocardial Infarction; Myocardium; Pyridones; Reperfusion Injury; Ventricular Remodeling

2018
Pirfenidone alleviates lung ischemia-reperfusion injury in a rat model.
    The Journal of thoracic and cardiovascular surgery, 2019, Volume: 158, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Cytokines; Cytoprotection; Disease Models, Animal; Inflammation Mediators; Lung; Lung Injury; Lung Transplantation; Male; Pyridones; Rats, Wistar; Reperfusion Injury; Signal Transduction; Warm Ischemia

2019
Commentary: No one drug does only one thing in only one setting.
    The Journal of thoracic and cardiovascular surgery, 2019, Volume: 158, Issue:1

    Topics: Animals; Pyridones; Rats; Reperfusion Injury

2019
Commentary: Antifibrotic agents in the postoperative period: Friends or foes?
    The Journal of thoracic and cardiovascular surgery, 2019, Volume: 158, Issue:1

    Topics: Animals; Humans; Postoperative Period; Pyridones; Rats; Reperfusion Injury

2019
Pirfenidone attenuates ischaemia-reperfusion injury in the rat small intestine.
    Clinical and experimental pharmacology & physiology, 2002, Volume: 29, Issue:11

    Topics: Animals; Female; Intestine, Small; Ischemia; Pyridones; Rats; Rats, Wistar; Reperfusion Injury

2002
Pirfenidone protects endotoxin-induced liver injury after hepatic ischemia in rats.
    Transplantation proceedings, 2004, Volume: 36, Issue:7

    Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspartate Aminotransferases; Endotoxins; Ischemia; Liver; Male; Pyridones; Rats; Rats, Sprague-Dawley; Reperfusion Injury

2004
Pirfenidone: a novel potential therapeutic agent in the management of chronic allograft rejection.
    Transplantation proceedings, 2007, Volume: 39, Issue:7

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Clinical Trials as Topic; Fibrinolytic Agents; Graft Rejection; Humans; Lung Transplantation; Pulmonary Fibrosis; Pyridones; Reperfusion Injury

2007